从干细胞到皮肤:ADSCP6在改变痕治疗中的作用
Jun Li1, Siqi Zeng1, Beibei Zhou2
1Department of Plastic&Cosmetic Surgery, Women's Hospital of Nanjing Medical University (Nanjing Women and Children's Healthcare Hospital), China.
Biochemical pharmacology
|May 10, 2025
概括
脂质衍生干细胞6 (ADSCP6) 通过降低原体调节和向NF-κB通路,有效减少过度缩性痕. 这种还促进了伤口愈合和血管生成,显示了治疗潜力.
科学领域:
- 生物医学科学 生物医学科学
- 再生医学是一种再生医学.
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 过度缩性痕是由异常的伤口愈合引起的,其特征是过度的纤维细胞活动,细胞外基质 (ECM) 失调和炎症.
- 来自脂肪衍生干细胞 (ASC) 的生物活性已经显示出调节痕形成的潜力.
- 以前的研究发现了ASCs的痕调节,需要对其机制进行进一步的研究.
研究的目的:
- 阐明由脂肪衍生干细胞6 (ADSCP6) 抑制高变性痕的机制.
- 评估ADSCP6在痕管理和伤口愈合方面的体外和体内疗效.
- 通过ADSCP6.6调节的分子目标和途径的识别.
主要方法:
- 在体外研究中,使用人类高性痕纤维细胞 (HSF) 来评估原和ACTA2表达.
- 在小鼠切割伤口模型中,在体内局部给予ADSCP6.
- 转录组定型 (RNA-seq) 和KEGG通路分析以确定差异表达的基因和信号通路.
- 蛋白质相互作用测试 (拉向下拉,细胞热转移测试) 和西部斑点测试以确定结合伙伴并确认蛋白质表达.
- 对NF-κB通路的功能验证,对FAK,STAT3和SMAD2蛋白水平的评估,以及对巨受条件介质效应的评估.
- 使用人静脉内皮细胞 (HUVEC) 管形成试验评估ADSCP6的亲血管性活性.
主要成果:
- ADSCP6显著降低了HSF中的I型原蛋白和ACTA2表达,但没有影响细胞增殖或细胞亡.
- 在小鼠模型中,局部ADSCP6在体内应用加速了伤口愈合和降低了原蛋白含量.
- RNA-seq确定了328个差异表达的基因,KEGG通路丰富突出了NF-κB信号通路作为关键目标.
- KANK2和ADGRE2/EMR2被确定为ADSCP6结合的合作伙伴,NF-κB1 (p50) 表达被上调.
- 阻断NF-κB通路消除了ADSCP6的抗纤维素作用,ADSCP6降低了FAK,STAT3和SMAD2蛋白水平.
- ADSCP6治疗增强了HUVEC管体生成,表明了亲血管性活性.
结论:
- ADSCP6作为一种多功能治疗,同时减轻纤维化的进展,加速伤口愈合.
- 通过调节NF-κB信号通路和下游目标来调节ADSCP6的抗纤维作用.
- ADSCP6显示出显著的潜力,作为一种新型治疗候选药物,用于临床治疗高变性痕和伤口愈合.
相关概念视频
Clinical Applications of Epidermal Stem Cells
2.6K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.6K
Renewal of Skin Epidermal Stem Cells
2.4K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.4K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Mesenchymal Stem Cells
4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Induced Pluripotent Stem Cells
21.7K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
21.7K


